Assay

Financial-condition grades for SEC filers

Company Report · as of Oct 9, 2026


HomeCompaniesSectorsCalendarLast night

Caring Brands, Inc.CABR · chemicals
GradeNonecomputable_factors_below_threshold: 3 of 14 inputs computable; 7 are required
Reliability0.76 AUCfailure model, filers with under $12.5M assets; 95% interval 0.65 to 0.86; 63 events, 2020 to 2025
Peer failure rate0.60% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025
Size bandunder $12.5M assetstotal assets $2.3M[1]
Standard universeoutsiderevenue above $1M and assets above $10M[1-2]
Warningsthin data, degenerate inputs · fortress balance sheetnot computable: dilution, short runway, distress
Inputs computable3 of 14
Graded fromfilings received through Mar 31, 2026192 days before the rescan; every figure keyed to the SEC receipt date
Last close$1.202026-10-06; market equity $12.4M; iex feed
Price used in gradeNone
Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history
$1$1.5DecJanFebMarAprMayJunJulAugSepOct$1.16
ABCDE20132014201520162017201820192020202120222023202420252026

Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date.

Open this report as it stood on

Letter setLetterPercentileBand
Jan 21, 2012nonen/a
Apr 21, 2026nonen/aQ1

Each date opens the report as it stood on that rescan.

Business, in the company's words. Opening of Item 1 of the 10-K received Mar 31, 2026; the document on sec.gov.

are a wellness consumer products company. We offer several over-the-counter (OTC) and cosmetic consumer products. Our product pipeline includes a diverse range of products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women’s sexual wellness products, catering to diverse health and wellness needs. Our method of operation ensures that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability.

Warnings [top]

Thin data. 3 of 14 grade factors are computable; minimum is 7
Degenerate inputs. latest revenue or assets are at or below the $100,000 validity floor[1-2]
Fortress balance sheet. cash minus debt is 2,130,582 USD; Altman Z is not used[3-4]

7 checks ran; none of them enters the letter. The checks are listed on the warnings screen.

The Fourteen Inputs [top]

Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.

InputPercentile, 0 to 100ValueSourcePeer medianPercentilePeersPeriod end
Profitability, sleeve percentile 95.5
Gross profitability0.1%[1,5]21.3%95.53592025-12-31
Return on invested capitalnot computable9.5%
one or more required annual facts are missing
Accruals rationot computable(4.2%)
a prior annual assets observation is required
Gross margin stability, five yearsnot computable2.2 pts
five annual gross margins are required; found 1
Solvency, sleeve percentile 47.4
Twelve-month failure probabilitynot computable0.05%
market price is missing at 2025-09-30
Altman Z double-prime(11.76)[1,6-11]3.4191.03012025-12-31
Net debt to EBITDAnot computable1.88x
one or more required annual facts are missing
Interest coveragenot computable4.16x
one or more required annual facts are missing
Current ratio13.16x[6-7]2.20x3.84232025-12-31
Growth and financing
Revenue growth, three-year compoundnot computable1.2%
four annual observations are required; found 1
Free cash flow growth, three-year compoundnot computable12.6%
four consecutive annual FCF observations are required; found 0
Reinvestment ratenot computable24.3%
one or more required annual facts are missing
Asset growth, three yearsnot computable2.9%
four annual observations are required; found 1
Net share issuance, one yearnot computable0.0%
two annual share counts are required; found 1

Gross profitability. Revenue less cost of goods sold, over total assets.

Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.

Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.

Twelve-month failure probability. CHS model; lower is stronger.

Net debt to EBITDA. Lower is stronger.

Net share issuance, one year. Split-adjusted; lower is stronger.

Among 331 Peers [top]

What the Price Implies [top]

Market measures at the 2026-10-06 close. None enters the grade. Percentile among graded peers with the same measure.

MeasureValuePeer medianPercentileReading
Twelve-month price change, skipping the latest monthnot computable13.8%missing required 12-1 monthly returns: 2025-11, 2025-10
Distance from 52-week high(28.0%)(24.2%)43closer to its high than 43 of 100 peers
EBIT to enterprise value(57.8%)3.9%2pricier than 98 of 100 peers
Free cash flow yieldnot computable3.2%required accounting or market input is missing
Book value to price(0.23)0.392pricier than 98 of 100 peers
Sales to price0.000.570pricier than 100 of 100 peers
Composite equity issuance, five yearsnot computable(9.9%)a share count from five years earlier is required
Relative strength against the sector, log excess returnnot computable(0.02)missing required 12-1 monthly returns: 2025-11, 2025-10

Inputs: market equity $12.0M; EBIT -$5.9M; book equity -$2.7M; sales $4,215; debt $58,650; cash $1.8M[12].

Diagnostics [top]

Diagnostics do not feed the grade.

Piotroski F-score: None of 9, period end 2025-12-31
Return on assets above zeron/a
Operating cash flow above zero-$1.7M✗ fail[13]
Return on assets improvedn/a[14]
Operating cash flow exceeds net income$4.6M✓ pass[13-14]
Long-term leverage felln/a[1,15]
Current ratio improvedn/a[6-7]
No new shares issuedn/a[16]
Gross margin improvedn/a[2,5]
Asset turnover improvedn/a[2]
Cash, filings, liquidity
Cash and equivalentsn/a
Operating cash flow, four quartersn/a[13,17-19]
Months of runwaynot finite
four discrete operating-cash-flow quarters are required; found 3
Late filings, two years0
NT 10-K or NT 10-Q
Days since last periodic filing57
10-Q received Aug 13, 2026
Median daily dollar volume$39,753
63 sessions
Days since newest grade input192

Downloads [top]

Sources [top]

Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.

#ConceptXBRL tagValuePeriod endReceivedFormLinks
1assetsus-gaap:Assets$2.3M2025-12-312026-03-3110-Kfiling · viewer · series
2revenueus-gaap:Revenues$4,2152025-12-312026-03-3110-Kfiling · viewer · series
3cashus-gaap:CashAndCashEquivalentsAtCarryingValue$2.2M2025-12-312026-03-3110-Kfiling · viewer · series
4total debtus-gaap:LongTermDebt$58,6502025-12-312026-03-3110-Kfiling · viewer · series
5gross profitus-gaap:GrossProfit$2,3422025-12-312026-03-3110-Kfiling · viewer · series
6current assetsus-gaap:AssetsCurrent$2.3M2025-12-312026-03-3110-Kfiling · viewer · series
7current liabilitiesus-gaap:LiabilitiesCurrent$176,8442025-12-312026-03-3110-Kfiling · viewer · series
8retained earningsus-gaap:RetainedEarningsAccumulatedDeficit-$7.1M2025-12-312026-03-3110-Kfiling · viewer · series
9operating incomeus-gaap:OperatingIncomeLoss-$5.9M2025-12-312026-03-3110-Kfiling · viewer · series
10book equityus-gaap:StockholdersEquity$2.1M2025-12-312026-03-3110-Kfiling · viewer · series
11liabilitiesus-gaap:Liabilities$235,4942025-12-312026-03-3110-Kfiling · viewer · series
12shares outstandingdei:EntityCommonStockSharesOutstanding10,368,2262026-08-132026-08-1310-Qfiling · viewer · series
13operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$1.7M2025-12-312026-03-3110-Kfiling · viewer · series
14net incomeus-gaap:NetIncomeLoss-$6.3M2025-12-312026-03-3110-Kfiling · viewer · series
15long term debtus-gaap:LongTermDebtNoncurrent$58,6502025-12-312026-03-3110-Kfiling · viewer · series
16shares outstandingdei:EntityCommonStockSharesOutstanding12,341,5062026-03-302026-03-3110-Kfiling · viewer · series
17operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$1.0M2026-06-302026-08-1310-Qfiling · viewer · series
18operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$550,7942026-03-312026-05-1210-Qfiling · viewer · series
19operating cash flowus-gaap:NetCashProvidedByUsedInOperatingActivities-$631,8752025-09-302025-11-1410-Qfiling · viewer · series

Limitations [top]

Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.

Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.

Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.

Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.

Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.